Via practica 6/2008

MALIGNANT VENTRICULAR ARRYTHMYAS: PHARMACOLOGICAL TREATMENT AND ICD AS A PART OF HYBRID THERAPY

Malignant vetricular arrythmias are leading cause of sudden death. The most often ethiology is coronary artery disease, acute myocardial infarction and state after myocardial infarction, dilated cardiomyopathy, hypertrophic cardiomyopathy, arhythmognic right ventricular dysplasia, long QT syndrome, Brugada syndrome, myokarditis, etc. Clinical picture depends mostly on ventricular rate and associated heart disease. Recently there is a massive expansion of ICD implants and a clear decline of chronical usage of class I antiarhythmics (mortality increase). The major task of ICD is sudden cardiac death prevention. ICD with optimal pharmacotherapy is the best therapy for malignant ventricular arrythmias.

Keywords: ventricular tachycardia, ventricular fibrilation, cardioverter – defibrillator.